BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6370297)

  • 1. Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).
    Zwaan FE; Hermans J; Barrett AJ; Speck B
    Br J Haematol; 1984 Apr; 56(4):645-53. PubMed ID: 6370297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).
    Zwaan FE; Hermans J; Barrett AJ; Speck B
    Br J Haematol; 1984 Sep; 58(1):33-42. PubMed ID: 6380563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow transplantation for acute leukaemia in first remission.
    Gale RP; Kay HE; Rimm AA; Bortin MM
    Lancet; 1982 Nov; 2(8306):1006-9. PubMed ID: 6127500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.
    Beelen DW; Quabeck K; Mahmoud HK; Schaefer UW; Becher R; Schmidt CG; Bamberg M; Quast U; Grosse-Wilde H; Haralambie E
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1665-71. PubMed ID: 3322846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone-marrow transplantation for acute lymphoblastic leukaemia.
    Gale RP; Kersey JH; Bortin MM; Dicke KA; Good RA; Zwaan FE; Rimm AA
    Lancet; 1983 Sep; 2(8351):663-7. PubMed ID: 6136805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Hermans J; Labopin M; Apperley J; Gorin NC; Gratwohl A
    Leuk Lymphoma; 1996 Dec; 24(1-2):71-9. PubMed ID: 9049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow transplantation in panmyelopathy, acute leukemia and chronic myelocytic leukemia: results of the Ulm Transplantation Group].
    Arnold R; Schmeiser T; Friedrich W; Carbonell F; Goldmann SF; Heit W; Kohne E; Kurrle E; Röttinger E; Wannenmacher M
    Klin Wochenschr; 1984 Jun; 62(12):577-85. PubMed ID: 6434793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.
    Barrett AJ; Locatelli F; Treleaven JG; Gratwohl A; Szydło R; Zwaan FE
    Br J Haematol; 1991 Dec; 79(4):567-74. PubMed ID: 1772778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of bone marrow transplantation in leukaemia and aplastic anaemia.
    Storb R; Santos GW
    Clin Haematol; 1983 Oct; 12(3):721-37. PubMed ID: 6357579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
    Ringdén O; Labopin M; Gluckman E; Hows JM; Bradley BA; Kolb HJ; Fouillard L; Jacobsen N; Vernant JP; Witz F; Harousseau JL; Gorin NC
    Bone Marrow Transplant; 1997 May; 19(10):963-8. PubMed ID: 9169639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
    Fagioli F; Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
    Bone Marrow Transplant; 1994 Mar; 13(3):247-52. PubMed ID: 8199567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission.
    Bacigalupo A; Frassoni F; Van Lint MT; Pittaluga PA; Piaggio G; Repetto M; Congiu M; Vitale V; Scarpati D; Corvò R
    Acta Haematol; 1985; 74(1):23-6. PubMed ID: 3934903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R
    N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
    Leukemia; 1994 Jun; 8(6):924-8. PubMed ID: 8207985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.
    Frassoni F; Barrett AJ; Grañena A; Ernst P; Garthon G; Kolb HJ; Prentice HG; Vernant JP; Zwaan FE; Gratwohl A
    Br J Haematol; 1988 Nov; 70(3):317-20. PubMed ID: 3061443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors.
    Forman SJ; Krance RA; O'Donnell MR; Nademanee AP; Snyder DS; Fahey JL; Schmidt GM; Zaia JA; Lipsett JA; Findley DO
    Transplantation; 1987 May; 43(5):650-3. PubMed ID: 3554657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation.
    Lancet; 1988 Jun; 1(8599):1379-82. PubMed ID: 2898053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Gorin NC; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F
    Bone Marrow Transplant; 2000 May; 25(10):1053-8. PubMed ID: 10828865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.